{"id":24399,"date":"2019-01-10T11:00:09","date_gmt":"2019-01-10T16:00:09","guid":{"rendered":"https:\/\/ipo.org\/?p=24399"},"modified":"2019-01-21T11:04:33","modified_gmt":"2019-01-21T16:04:33","slug":"inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know","status":"publish","type":"post","link":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/","title":{"rendered":"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know"},"content":{"rendered":"
<\/div>\n
\n

*CORRECTION<\/span><\/b>:\u00a0 In\u00a0<\/span>Peerless Industries v. Crimson AV<\/span><\/i>\u00a0in the Northern District of Illinois (2018), the court found no inequitable conduct, rejecting defendant\u2019s argument citing\u00a0<\/span>Regeneron<\/span><\/i>.\u00a0 [An earlier IPO webinar announcement on Jan. 4 inaccurately described the court\u2019s decision<\/span>.]<\/span><\/p>\n<\/div>\n

\n

__________________________________________________________________________<\/span><\/span><\/p>\n<\/div>\n

\n

A Federal Circuit decision in 2017 found a Regeneron patent unenforceable due to inequitable conduct based partly on the behavior of litigators. This widened the scope of possible inequitable conduct claims, which traditionally focused only on the prosecution of the patent before the USPTO.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div>\n

\n
\n
    \n
  • Peerless Industries v. Crimson AV\u00a0<\/span><\/span><\/i>in the Northern District of Illinois (2018), where the court found no inequitable conduct, rejecting defendant\u2019s argument citing\u00a0<\/span><\/span>Regeneron<\/span><\/span><\/i>.<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div>\n
    \n

    Critics of the decision hoped first for an\u00a0<\/span><\/span>en banc<\/span><\/span><\/i>\u00a0rehearing by the Federal Circuit \u2014 and then that the Supreme Court would grant Regeneron\u2019s petition for certiorari. Those hopes were dashed late last year.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div>\n

    \n

    This webinar features experts who will assess\u00a0<\/span><\/span>Regeneron\u2019s\u00a0<\/span><\/span><\/i>significant ongoing impact on litigation and patent prosecution. The panel includes a patent prosecutor who urged the Supreme Court to grant cert. to Regeneron, a leading academic expert on legal ethics and IP, and a patent litigator who represented\u00a0<\/span><\/span>Therasense<\/span><\/span>\u00a0at the\u00a0<\/span><\/span>en banc<\/span><\/span><\/i>\u00a0Federal Circuit in\u00a0<\/span><\/span>Therasense<\/span><\/span><\/i>\u00a0v. Becton Dickenson<\/span><\/span><\/i>\u00a0(2011), a case that raised the bar for proving inequitable conduct. The panelists will discuss:<\/span><\/span>\u00a0<\/span><\/p>\n<\/div>\n

    \n
      \n
    • Peerless Industries v. Crimson AV\u00a0<\/span><\/span><\/i>in the Northern District of Illinois (2018), where the court found no inequitable conduct, rejecting defendant\u2019s argument citing\u00a0<\/span><\/span>Regeneron<\/span><\/span><\/i>.<\/span><\/span>\u00a0<\/span><\/li>\n
    • Howmedica Osteonics v. Zimmer<\/span><\/span><\/i>, in the District of New Jersey (2018), where the court granted the defendant\u2019s motion for $13 million in attorney fees and costs in part because of plaintiff\u2019s inequitable conduct before the USPTO<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n
      \n
      \n
        \n
      • The relationship between materiality under\u00a0<\/span><\/span>Therasense<\/span><\/span><\/i>, the court\u2019s claim construction, and the prosecutor\u2019s judgment about what is cumulative<\/span><\/span>\u00a0<\/span><\/li>\n
      • Approaches that may be taken by defendants\u2019 experts at trial<\/span><\/span>\u00a0<\/span><\/li>\n
      • The reinforced imperative for patent owners who are plaintiffs to closely oversee aggressive litigation counsel<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div>\n
        \n

        Speakers:\u00a0<\/span><\/span>\u00a0<\/span><\/p>\n<\/div>\n

        \n
          \n
        • Prof. David Hricik,\u00a0<\/span><\/span>Mercer University School of Law\u00a0<\/span><\/span><\/i>\u00a0<\/span><\/li>\n
        • Kevin Noonan,\u00a0<\/span><\/span>McDonnell\u00a0<\/span><\/span><\/i>Boehnen<\/span><\/span><\/i>\u00a0Hulbert & Berghoff LLP<\/span><\/span><\/i>\u00a0<\/span><\/span>\u00a0<\/span><\/li>\n
        • Rohit Singla,\u00a0<\/span><\/span>Munger, Tolles & Olson LLP<\/span><\/span><\/i><\/li>\n<\/ul>\n<\/div>\n<\/div>\n
          \n
          <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

          *CORRECTION:\u00a0 In\u00a0Peerless Industries v. Crimson AV\u00a0in the Northern District of […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-24399","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nInequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know - Intellectual Property Owners Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know - Intellectual Property Owners Association\" \/>\n<meta property=\"og:description\" content=\"*CORRECTION:\u00a0 In\u00a0Peerless Industries v. Crimson AV\u00a0in the Northern District of [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/\" \/>\n<meta property=\"og:site_name\" content=\"Intellectual Property Owners Association\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPOAssociation\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-10T16:00:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-01-21T16:04:33+00:00\" \/>\n<meta name=\"author\" content=\"ipoadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipo\" \/>\n<meta name=\"twitter:site\" content=\"@ipo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ipoadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/\"},\"author\":{\"name\":\"ipoadmin\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/8226b50acbf234bbf0f5d70f4a84ba47\"},\"headline\":\"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know\",\"datePublished\":\"2019-01-10T16:00:09+00:00\",\"dateModified\":\"2019-01-21T16:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/\",\"name\":\"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know - Intellectual Property Owners Association\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\"},\"datePublished\":\"2019-01-10T16:00:09+00:00\",\"dateModified\":\"2019-01-21T16:04:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ipo.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"name\":\"Intellectual Property Owners Association\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ipo.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\",\"name\":\"Intellectual Property Owners Association\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"contentUrl\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"width\":570,\"height\":226,\"caption\":\"Intellectual Property Owners Association\"},\"image\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPOAssociation\\\/\",\"https:\\\/\\\/x.com\\\/ipo\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ipoassociation\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/8226b50acbf234bbf0f5d70f4a84ba47\",\"name\":\"ipoadmin\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/author\\\/ipoadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know - Intellectual Property Owners Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/","og_locale":"en_US","og_type":"article","og_title":"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know - Intellectual Property Owners Association","og_description":"*CORRECTION:\u00a0 In\u00a0Peerless Industries v. Crimson AV\u00a0in the Northern District of [...]","og_url":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/","og_site_name":"Intellectual Property Owners Association","article_publisher":"https:\/\/www.facebook.com\/IPOAssociation\/","article_published_time":"2019-01-10T16:00:09+00:00","article_modified_time":"2019-01-21T16:04:33+00:00","author":"ipoadmin","twitter_card":"summary_large_image","twitter_creator":"@ipo","twitter_site":"@ipo","twitter_misc":{"Written by":"ipoadmin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/#article","isPartOf":{"@id":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/"},"author":{"name":"ipoadmin","@id":"https:\/\/ipo.org\/#\/schema\/person\/8226b50acbf234bbf0f5d70f4a84ba47"},"headline":"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know","datePublished":"2019-01-10T16:00:09+00:00","dateModified":"2019-01-21T16:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/"},"wordCount":357,"publisher":{"@id":"https:\/\/ipo.org\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/","url":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/","name":"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know - Intellectual Property Owners Association","isPartOf":{"@id":"https:\/\/ipo.org\/#website"},"datePublished":"2019-01-10T16:00:09+00:00","dateModified":"2019-01-21T16:04:33+00:00","breadcrumb":{"@id":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipo.org\/index.php\/inequitable-conduct-after-regeneron-what-litigators-patent-prosecutors-and-patent-owners-need-to-know\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipo.org\/"},{"@type":"ListItem","position":2,"name":"Inequitable Conduct After Regeneron: What Litigators, Patent Prosecutors, and Patent Owners Need to Know"}]},{"@type":"WebSite","@id":"https:\/\/ipo.org\/#website","url":"https:\/\/ipo.org\/","name":"Intellectual Property Owners Association","description":"","publisher":{"@id":"https:\/\/ipo.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipo.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ipo.org\/#organization","name":"Intellectual Property Owners Association","url":"https:\/\/ipo.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/","url":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","contentUrl":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","width":570,"height":226,"caption":"Intellectual Property Owners Association"},"image":{"@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPOAssociation\/","https:\/\/x.com\/ipo","https:\/\/www.linkedin.com\/company\/ipoassociation\/"]},{"@type":"Person","@id":"https:\/\/ipo.org\/#\/schema\/person\/8226b50acbf234bbf0f5d70f4a84ba47","name":"ipoadmin","url":"https:\/\/ipo.org\/index.php\/author\/ipoadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/24399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/comments?post=24399"}],"version-history":[{"count":1,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/24399\/revisions"}],"predecessor-version":[{"id":24400,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/24399\/revisions\/24400"}],"wp:attachment":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/media?parent=24399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/categories?post=24399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/tags?post=24399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}